AEON Gains FDA Feedback On ABP-450 Biosimilar Pathway2 reports from 2 outlets in 1 language · first reported 2026-09-30 12:19 UTC · updated 2026-09-30 12:37 UTC · JSONScience & technologyAeonUnited States Food and Drug AdministrationReportsAEON Gains FDA Feedback On ABP-450 Biosimilar Pathwayrttnews.com · en · 2026-09-30 12:37 UTCAEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450manilatimes.net · en · 2026-09-30 12:19 UTC